EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Skeletal muscle and childhood cancer: Where are we now and where we go from here

Chelsea G Goodenough iD, Robyn E Partin iD, Kirsten K Ness iD

Aging and Cancer · 2021-06 · 2 (1-2) · 13-35

DOI: 10.1002/aac2.12027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging and Cancer, online erschienen am 20.05.2021. Verfasst von Chelsea G Goodenough und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Cancer Control Department, St. Jude Children's Research Hospital, Memphis, TN, USA. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skeletal muscle (muscle) is essential for physical health and for metabolic integrity, with sarcopenia (progressive muscle mass loss and weakness), a precursor of aging and chronic disease. Loss of lean mass and muscle quality (force generation per unit of muscle) in the general population are associated with fatigue, weakness, and slowed walking speed, eventually interfering with the ability to maintain physical independence, and impacting participation in social roles and quality of life. Muscle mass and strength impairments are also documented during childhood cancer treatment, which often persist into adult survivorship, and contribute to an aging phenotype in this vulnerable population. Although several treatment exposures appear to confer increased risk for loss of mass and strength that persists after therapy, the pathophysiology responsible for poor muscle quantity and quality is not well understood in the childhood cancer survivor population. This is partly due to limited access to both pediatric and adult survivor muscle tissue samples, and to difficulties surrounding noninvasive investigative approaches for muscle assessment. Because muscle accounts for just under half of the body's mass and is essential for movement, metabolism, and metabolic health, understanding mechanisms of injury responsible for both initial and persistent dysfunction is important and will provide a foundation for intervention. The purpose of this review is to provide an overview of the available evidence describing associations between childhood cancer, its treatment, and muscle outcomes, identifying gaps in current knowledge.

Schlagwörter

Stichwörter der Autor:innen

childhood cancermuscle fitnessmuscle healthmuscle massmuscle outcomesmuscle qualityskeletal muscle

Autor:innen und Institutionen

  • Epidemiology and Cancer Control Department, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Chelsea G Goodenough, Robyn E Partin, Kirsten K Ness

Förderung

  • NCI NIH HHS

Zitieren

APA

Goodenough, C. G., Partin, R. E., & Ness, K. K. (2021). Skeletal muscle and childhood cancer: Where are we now and where we go from here. Aging and Cancer, 2(1-2), 13-35. https://doi.org/10.1002/aac2.12027

Vancouver

Goodenough CG, Partin RE, Ness KK. Skeletal muscle and childhood cancer: Where are we now and where we go from here. Aging and Cancer. 2021;2(1-2):13-35. doi:10.1002/aac2.12027

BibTeX
@article{Goodenough2021,
  author = {Goodenough, Chelsea G and Partin, Robyn E and Ness, Kirsten K},
  title = {Skeletal muscle and childhood cancer: Where are we now and where we go from here},
  journal = {Aging and Cancer},
  year = {2021},
  volume = {2},
  number = {1-2},
  pages = {13--35},
  doi = {10.1002/aac2.12027}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche